SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective
Release Date: 06/24/2021
Neurology® Podcast
Dr. Gregg Day talks with Dr. Avi Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS), about COVID brain fog and other cognitive syndromes. Read the .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Prof. Sarosh Irani about the use of corticosteroids as a first-line agent in the treatment of LGI1 antibody encephalitis.
info_outlineNeurology® Podcast
Dr. Gregg Day talks with Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke, about NINDS's mission and clinical neurology.
info_outlineNeurology® Podcast
Dr. Jeff Burns talks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Research Center, about Medicare's recent decision to officially limit Aduhelm (aducanumab) coverage to patients in clinical trials. Read the .
info_outlineNeurology® Podcast
Dr. Karen Hirsch talks with Dr. Linnéa Grindegård about the association between EEG patterns and serum neurofilament light as a marker of neuroaxonal injury after cardiac arrest. Read the .
info_outlineNeurology® Podcast
Drs. B.J. Hicks and Andy Southerland talk with Dr. Scott Mendelson about racial and ethnic disparities in the rates of declination of thrombolysis in patients with acute ischemic stroke. Read the .
info_outlineNeurology® Podcast
Dr. Justin Abbatemarco talks with Prof. Gráinne Gorman about the use of L-arginine in the treatment of mitochondrial encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Read the .
info_outlineNeurology® Podcast
Dr. Fábio Nascimento talks with Dr. Elaine Pang about the identification and characterization of pure sleep epilepsy after first-ever seizures from sleep in adults. Read the .
info_outlineNeurology® Podcast
The June 2022 replay of past episodes showcases a selection of interviews about the impact of the FDA's approval of aducanumab for the treatment of Alzheimer disease (AD). This episode features illuminating conversations with Drs. Gregg Day, Ron Petersen, and Jason Karlawish on the clinical science guiding amyloid-based treatments for AD, the importance of patient participation when considering the use of aducanumab, and the business of Alzheimer disease, respectively. This month's Recall concludes with an interview featuring Pulitzer Prize-winning journalist Pam Belluck on Medicare's...
info_outlineNeurology® Podcast
Dr. Jeff Ratliff talks with Dr. Meredith Bock about the association of motor, non-motor, and behavioral symptoms with health-related quality of life in people with Parkinson disease. Read the .
info_outlineDr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.